Drug Screening on Digital Microfluidics for Precision Medicine
Ongoing Projects
PI, FDCT 0168/2023/RIA3, Cancer drug screening based on single-cell impedance detection on integrated circuit chip, MOP 2,484,700, 2024-2027
PI, SHMDF-OIRFS/2024/001, Primary tumor drug screening on digital microfluidics, Outstanding Innovation Research Funding Scheme, MOP 300,000, 2024
PI, MYRG-GRG2023-00034-IME, Deep droplet digital PCR (dddPCR) on digital microfluidics, MOP 640,000, 2024-2025
PI, Huafa-UM Joint Project, Portable drug screening platform based on digital microfluidics, RMB 4,140,000, 2022-2025
PI, FDCT 0029/2021/A1, Digital microfluidic system for cancer drug screening, MOP 1,933,000,, 2021-2024
Completed Projects
PI, FDCT 0072/2020/AGJ, Digital microfluidic system for breast cancer biomarker detection and drug screening, MOP 977,000, 2021-2023
PI, Zhuhai Science and Technology Innovation and Development of Special Funds, EF019/IME-JYW/2021/ZHSTIB, Development and industrialization of digital microfluidics for high throughput multi-respitary-pathogen detection, RMB 160,000, 2021-2023
PI, MYRG 2020-00078-IME, Precise drug delivery on digital microfluidics for drug screening, MOP 520,000, 2022-2023
PI, FDCT 0053/2019/A1, Pico-pipette in Digital Microfluidic System for Precise Sample Delivery with Wide Range, MOP 2,243,000, 2019-2022
PI, MYRG 2018-00114-AMSV, 3D Micro-structured Digital Microfluidic System with Closed-Loop Image Analysis for Cell Recognition in Precision Medicine Investigations, MOP 1,455,000, 2019-2022
PI, Guangzhou Science and Technology Innovation and Development of Special Funds, EF009/AMSV-JYW/2018/GSTIC, Development and Industrialization of Drug Resistant Tuberculosis Detection Kit and Equipment Based on Digital Microfluidic PCR and HRM Platform, RMB 700,000, Collaborating with DaAn Gene Ltd., 2019-2022
PI, FDCT 110/A3/2016, Integration of Digital & Channel Microfluidic Systems for High-throughput Drug Screening, MOP 1,923,000, 2017-2020